attention deficit hyperactivity disorder/비만증

FIELD OF THE INVENTION The present invention relates to transdermal devices and methods for controllable dispensing of a nutraceutical or an active substance such as a chemical substance, a medication, a drug, a stimulant or the like, to a human or other mammal for purposes of promoting longevity,

FIELD OF THE INVENTION The present invention relates to transdermal devices and methods for controllable dispensing of a nutraceutical or an active substance such as a chemical substance, a medication, a drug, a stimulant or the like, to a human or other mammal for purposes of promoting longevity,

FIELD OF THE INVENTION The present invention relates to transdermal devices and methods for controllable dispensing of a nutraceutical or an active substance such as a chemical substance, a medication, a drug, a stimulant or the like, to a human or other mammal for purposes of promoting longevity,

FIELD OF THE INVENTION The present invention relates to transdermal devices and methods for controllable dispensing of a nutraceutical or an active substance such as a chemical substance, a medication, a drug, a stimulant or the like, to a human or other mammal for purposes of promoting longevity,

FIELD OF THE INVENTION The present invention relates to transdermal devices and methods for controllable dispensing of a nutraceutical or an active substance such as a chemical substance, a medication, a drug, a stimulant or the like, to a human or other mammal for purposes of promoting longevity,

This invention relates generally to electrical stimulation therapy for medical disorders, more specifically to neuromodulation therapy for obesity, eating disorders, and anxiety disorders with an external pulse generator (stimulator) containing predetermined programs, and adapted to be used with an

FIELD OF INVENTION This invention relates generally to medical device used for adjunct (add-on) treatment for obesity, more specifically a medical device used for adjunct (add-on) therapy for obesity and compulsive eating disorders with electrical stimulation neuromodulation using an implanted

FIELD OF THE INVENTION The present invention relates to benzofuro[3,2-c]pyridine and azepine analogs as serotonin sub-type 6 (5-HT.sub.6) modulators and uses thereof. BACKGROUND OF THE INVENTION Various central nervous system (CNS) disorders such as anxiety, depression, motor disorders, etc., are

FIELD OF THE INVENTION The present application provides stereoisomers with high affinity for adrenergic receptors which may be used in pharmaceutical compositions and as therapeutic agents in a variety of methods. The present stereoisomers can also be used to identify other compounds that bind to

FIELD OF THE INVENTION The present application provides stereoisomers with high affinity for adrenergic receptors which may be used in pharmaceutical compositions and as therapeutic agents in a variety of methods. The present stereoisomers can also be used to identify other compounds that bind to

BACKGROUND OF THE INVENTION Obesity, defined as excess adiposity for a given body size, results from a chronic imbalance between energy intake and energy expenditure. Body mass index (BMI, kg/m.sup.2) is an accepted clinical estimate of being overweight (BMI 25 to 30) and of obesity (BMI>30). A

The present invention relates to new azabicyclic compounds, to a process for their preparation and to pharmaceutical compositions containing them. The compounds of the present invention are especially valuable from a pharmacological point of view for their interaction with central histaminergic

FIELD OF THE INVENTION The invention relates to amphetamine compounds, more particularly to amphetamine prodrugs comprising amphetamine covalently bound to a chemical moiety. The invention also relates to pharmaceutical compositions comprising the amphetamine compounds, and to methods of

FIELD OF THE INVENTION The invention relates to amphetamine compounds, more particularly to amphetamine prodrugs comprising amphetamine covalently bound to a chemical moiety. The invention also relates to pharmaceutical compositions comprising the amphetamine compounds, and to methods of

FIELD OF THE INVENTION The invention relates to amphetamine compounds, more particularly to amphetamine prodrugs comprising amphetamine covalently bound to a chemical moiety. The invention also relates to pharmaceutical compositions comprising the amphetamine compounds, and to methods of